Monoclonal B-cell lymphocytosis: A reappraisal of its clinical implications

Leukemia and Lymphoma

Volumn 53, Issue 9, 2012, Pages 1660-1665

  Molica, Stefano ^a   Mauro, Francesca Romana ^b   Molica, Matteo ^b   Giudice, Ilaria Del ^b   Foà, Robin ^b  

^a PUGLIESE CIACCIO HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

clinical implications; Monoclonal B cell lymphocytosis; natural history

Indexed keywords

CD103 ANTIGEN; CD19 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD79B ANTIGEN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN;

ANXIETY DISORDER; B LYMPHOCYTE; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL EVALUATION; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISTRESS SYNDROME; FOLLOW UP; HUMAN; INCIDENCE; LYMPHOCYTE COUNT; LYMPHOCYTOMA; MASS SCREENING; MONOCLONAL B CELL LYMPHOCYTOSIS; MONOCLONAL IMMUNOGLOBULINEMIA; PATIENT COUNSELING; PATIENT MONITORING; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW;

B-LYMPHOCYTES; CHROMOSOME ABERRATIONS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; MUTATION; PROGNOSIS;

EID: 84865029151     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.666542     Document Type: Review

References (39)

1. C heson BD, Bennett JM, Rai KR, et al. Guidelines for clinical protocols for chronic lymphocytic leukemia: Recommendations of the National Cancer Institute-sponsored working group. Am J Hematol 1988;29:152-163.
2. Cheson BD, Bennett JM, Grever M, et al. National Cancer Institutesponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 1996;87:4990-4997.
3. Montserrat E, Viñolas N, Reverter JC, et al. Natural history of chronic lymphocytic leukemia: on the progression and prognosis of early clinical stages. Nouv Rev Fr Hematol 1988;30:359-361.
4. French Cooperative Group on Chronic Lymphocytic Leukaemia. Natural history of stage A chronic lymphocytic leukaemia in untreated patients. Br J Haematol 1990;76:45-57.
5. M olica S. Survival and disease progression studies in early chronic lymphocytic leukemia. Blood 1991;78:895-899.
6. Ghia P, Prato G, Scielzo C, et al. Monoclonal CD5 and CD5 B-lymphocyte expansions are frequent in the peripheral blood of the elderly. Blood 2004;103:2337-2342.
7. R awstron A, Green M, Kuzmicki A, et a l. Monoclonal B lymphocytes with the characteristics of indolent chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts. Blood 2002;100:635-639.
8. Marti GE, Rawstron AC, Ghia P, et al. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005;130:325-332.
9. Dagklis A, Fazi C, Sala C, et a l. Th e immunoglobulin gene repertoire of population CLL-like MBL is diff erent from CLL: diagnostic implications for clinical monitoring. Blood 2009;114:26-32.
10. Nieto WG, Almeida J, Romero A, et a l. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor fl ow cytometry approach. Blood 2009;114:33-37.
11. Scarf ó L, Dagklis A, Scielzo C, et al. CLL-like monoclonal B-cell lymphocytosis: Are we all bound to have it? Semin Cancer Biol 2010;20:384-390.
12. R awstron AC, Shanafelt T, Lanasa MC, et a l. Diff erent biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytometry B Clin Cytom 2010;78(Suppl. 1):S19-S23.
13. R awstron AC, Bennett FL, O'Connor SJ, et al. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia. N Engl J Med 2008;359:575-583.
14. Shanafelt TD, Kay NE, Jenkins G, et al. B-cell count and survival: diff erentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood 2009;113: 4188-4196.
15. Shanafelt TD, Kay NE, Rabe KG, et a l. Natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. J Clin Oncol 2009;27:3959-3963.
16. Rossi D, Sozzi E, Puma A, et a l. Th e prognosis of clinical monoclonal B cell lymphocytosis diff ers from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors. Br J Haematol 2009;146:64-75.
17. M olica S, Mauro FR, Giannarelli D, et a l. Diff erentiating chronic lymphocytic leukemia from monoclonal B-lymphocytosis according to clinical outcome: on behalf of the GIMEMA chronic lymphoproliferative diseases working group. Haematologica 2011;96: 277-283.
18. M arti GE, Faguet GB, Stewart C, et a l. Evolution of leukemic heterogeneity of human B-CLL lymphocytes between and within patients. Curr Top Microbiol Immunol 1992;182:303-311.
19. M arti GE, Faguet G, Bertin P, et a l. CD20 and CD5 expression in B-chronic lymphocytic leukemia (B-CLL). Ann NY Acad Sci 1992;651: 480-483.
20. B atata A, Shen B. Chronic lymphocytic leukemia with low lymphocyte count. Cancer 1993;71:2732-2738.
21. B yrd JC. Clonal lymphocytosis of unknown signifi cance (CLUS): what clues will CLUS yield? Blood 2002;100(Suppl. 1): Abstract 2777.
22. W ang C, Amato D, Rabah R, et a l. Diff erentiation of monoclonal B lymphocytosis of undetermined signifi cance (MLUS) and chronic lymphocytic leukemia (CLL) with weak CD5 expression from CD5(-) CLL. Leuk Res 2002;26:1125-1129.
23. H allek M, Cheson BD, Catovsky D, et al.; International Workshop on Chronic Lymphocytic Leukemia. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia (IWCLL) updating the National Cancer Institute-Working Group (NCI-WG) 1996 guidelines. Blood 2008;111:5446-5456.
24. H anson CA, Kurtin PJ, Dogan A. Th e proposed diagnostic criteria change for chronic lymphocytic leukemia: unintended consequences? Blood 2009;113:6495-6496.
25. M olica S, Gentile M, Mauro FR, et a l. An increased number of individuals with clinically recognized monoclonal B-cell lymphocytosis (MBL) characterizes a recent database of chronic lymphocytic leukemia (CLL) Rai stage 0. Acta Haematol 2012;127:149-151.
26. S hanafelt TD, Ghia P, Lanasa MC, et a l. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia 2010;24:512-520.
27. L anasa MC, Allgood SD, Slager SL, et a l. Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL. Leukemia 2011;25:1459-1466.
28. Gibson SE, Swerdlow SH, Ferry JA, et a l. Reassessment of smalllymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis. Haematologica 2011;96:1144-1152.
29. Ghia P. Another piece of the puzzle: Is there a nodal monoclonalB-cell lymphocytosis? Haematologica 2011;96:1144-1152.
30. Molica S, Reverter JC, Alberti A, et a l. Timing of diagnosis and lymphocyte accumulation patterns in chronic lymphocytic leukemia: Analysis of their clinical signifi cance. Eur J Haematol 1990;44:277-281.
31. L andgren O, Albitar M, Ma W, et al. B-cell clones as early markers for chronic lymphocytic leukemia. N Engl J Med 2009;360:659-667.
32. M olica S, Fabris S, Cutrona G, et al. Diff erentiation on biological basis of monoclonal B-cell lymphocytosis (MBL) from chronic lymphocytic leukemia (CLL): Results of a prospective GISL (Gruppo Italiano Studio Linfomi) trial. Blood 2010;116(Suppl. 1): Abstract 1360.
33. Matos DM, Ismael SJ, Scrideli CA, et a l. Monoclonal B-cell lymphocytosis in fi rst-degree chronic lymphocytic leukaemia. Br J Haematol 2009;147:339-346.
34. F azi C, Scarfó L, Pecciarini L, et al. General population lowcount CLL-like MBL persists over time without clinical progression, though carrying the same cytogenetic abnormalities of CLL. Blood 2011;118:6618-6625.
35. M olica S. Quality of life in chronic lymphocytic leukemia: neglected issue. Leuk Lymphoma 2005;46:1709-1714.
36. Levin TT, Li Y, Riskind J, et a l. Depression, anxiety and quality of life in a chronic lymphocytic leukemia cohort. Gen Hosp Psychiatry 2007;29:251-256.
37. Rabe K, Cerhan JR, Hanson CA, et a l. Infectious complications among individuals with monoclonal B-cell lymphocytosis (MBL): prospective case-control study of newly diagnosed patients. Blood 2011;118(Suppl. 1): Abstract 3903.
38. R awstron AC, Yuille MR, Fuller J, et al. Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion. Blood 2002;100:2289-2290.
39. D el Giudice I, Mauro FR, De Propris MS, et al. Identifi cation of monoclonal B-cell lymphocytosis among sibling transplant donors for chronic lymphocytic leukemia patients. Blood 2009;114:2848-2849.